You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Infosys turns volatile ahead of Q3 earnings

Capital Market 

Infosys was up 0.12% to Rs 1,976.90 at 11:51 IST on BSE ahead of its Q3 December 2014 results at 12:30 noon today, 9 January 2015.

Meanwhile, the BSE Sensex was up 81.55 points, or 0.30%, to 27,356.26.

On BSE, so far 1.06 lakh shares were traded in the counter, compared with an average volume of 2.04 lakh shares in the past one quarter.

Trading in the stock was volatile. The stock rose 1.11% at the day's high of Rs 1,996.55 so far during the day. The stock fell 0.64% at the day's low of Rs 1,962 so far during the day.

The stock hit a 52-week high of Rs 2,200.50 on 1 December 2014. The stock hit a 52-week low of Rs 1,447 on 30 May 2014.

The stock had outperformed the market over the past one month till 8 January 2015, rising 0.30% compared with 3% fall in the Sensex. The scrip had also outperformed the market in past one quarter, rising 8.19% as against Sensex's 3.92% rise.

The large-cap company has an equity capital of Rs 574.24 crore. Face value per share is Rs 5.

Due to cross currency headwinds, analysts expects Infosys' management to prune the company's revenue growth guidance in dollar terms for the year ending 31 March 2015 (FY 2015). The IT major is widely expected to prune its FY 2015 dollar revenue growth to 7%-8%, from 7%-9%.

At the time of announcement of Q2 September 2014 results, Infosys had on 10 October 2014 retained its earlier guidance of 7% to 9% growth in revenue in dollar terms for FY 2015. At that time, the company had raised its revenue growth guidance in rupee terms due to rupee depreciation. The company had raised the revenue growth guidance for FY 2015 in rupee terms to 6.7%-8.7% from earlier 5.6%-7.6% at that time. The revised guidance was based on rupee dollar conversion rate of 61.

Infosys is a global leader in consulting, technology and outsourcing solutions.

Powered by Capital Market - Live News

First Published: Fri, January 09 2015. 11:49 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU